The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
America must win the AI race — and prepare for the worst

Related Posts

Ioneer Closes US$996 Million American Government Loan for...

January 22, 2025

SAGA Metals Engages Paul McGuigan as its Qualified...

June 5, 2025

Fintech Firm Velocity Raises US$10 Million for Enterprise...

May 29, 2025

​Tech 5: Tech Stocks Volatile as Recession Fears...

August 6, 2024

Hempalta Secures 90-Day FCC Forbearance Extension as Company...

July 5, 2025

Appointment of Managing Director

July 29, 2025

Sranan Gold Initiates Diamond Core Drilling Program on...

August 14, 2025

Crypto Market Update: Strategy Defends Balance Sheet Strength...

November 27, 2025

Bitcoin Reaches New Record High on Reserve Asset...

December 17, 2024

Altech – Cerenergy® Battery Project Funding Update

November 22, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,579)
    • Investing (4,760)
    • Politics (6,249)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved